Moderna Inc. (NASDAQ:MRNA) is one of the best mid cap growth stocks to invest in now. On June 12, the US FDA expanded the approval for Moderna’s respiratory syncytial virus/RSV vaccine, mRESVIA ...

The CDC's vaccine advisory committee is set to meet for the first time since HHS Secretary Robert F. Kennedy Jr. dismissed ...

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

Newer formulations are even more effective at preventing illnesses that commonly afflict seniors — perhaps even dementia.

The FDA has expanded the approval of mResvia to include active immunization in high-risk individuals 18 through 59 years of age.

Some older people are really eager to be vaccinated. Robin Wolaner, 71, a retired publisher in Sausalito, California, has ...

Former members of the ACIP are responding to their recent ousting by Robert F. Kennedy Jr in an editorial published in JAMA.

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

(Alliance News) - GSK PLC on Friday announced that Japan has accepted a regulatory application to expand the use of its respiratory syncytial virus [RSV] vaccine Arexvy.

RFK Jr.’s newly appointed CDC vaccine panel will not review HPV or meningitis vaccines but will vote on thimerosal, a ...

Frailty strongly predicts worse RSV outcomes in older adults, highlighting the need for targeted care as aging populations ...

“RFK Jr is not just crossing a red line for public health,” said Murray, a Democrat from Washington. “He is sprinting into ...